AXL expression displays a positive correlation with PD-L1 expression in lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutation, and abolition of AXL kinase activity inhibits PD-L1 mRNA expression in a lung adenocarcinoma cell line with EGFR mutation [8]. The gene discussed is AXL; the disease is lung adenocarcinoma.